About 40% of at-risk patients with COPD did not receive maintenance therapy despite having frequent or severe exacerbations.
A large study presented at the 2026 ATS International Conference shows that patients treated for COPD or pneumonia experience ...
Two phase 3, randomized trials of inhaled treprostinil for idiopathic pulmonary fibrosis (IPF) were conducted on the basis of preclinical and clinical evidence of an antifibrotic mechanism.
Pairing vulnerable, low-income patients with asthma coaches can improve outcomes and may also reduce costs associated with ...
Among hospitalized adults with acute exacerbation of COPD, pegtarazimod improved oxygen utilization and inflammatory ...
PULMONARY tuberculosis outcomes worsened in older patients with diabetes, kidney disease, malignancy, or multimorbidity.
Treatment options for managing your PH will depend on what type of pulmonary hypertension you have. Each type of pulmonary hypertension requires a tailored treatment plan that follows the latest ...
aDepartment of Respiratory Sciences, University of Leicester, Leicester, UK bDepartment of Respiratory Medicine, University Hospitals of Leicester, Leicester, UK cInstitute for Lung Health, National ...
fDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Gulu University, Gulu, Uganda gDepartment of Respiratory and Critical Medicine, Nanjing Drum Tower Hospital, Affiliated ...
Abstract: COPD is a lung disease that gets worse over time. It causes you to have trouble breathing (dyspnea), wheeze, and cough all the time. Because of the vital requirement for early identification ...
The human metapneumovirus or the HMPV has become a global concern right now. After a massive outbreak in China, two cases of ...
In the world’s fastest aging society, artificial intelligence is being used to make care calls to older adults who live alone and to fight dementia. By Choe Sang-Hun Reporting from Seoul, Bucheon , ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results